small molecule

BENDOPA

LEVODOPA

Loss of exclusivityloss of exclusivity
CompanyVALEANT PHARMACEUTICALS INTERNATIONAL

Drug detail

Brand nameBENDOPA
Active ingredientLEVODOPA
Strength500MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BENDOPA patent cliff — loss of exclusivity — | CliffBio